4861
|
|
|
Fibronectin type III and SPRY domain containing 1 |
GLFND, MIR1 |
|
4862
|
|
|
Fibronectin type III and SPRY domain containing 1 like |
CCDC10, CSDUFD1, FSD1CL, FSD1NL, MIR1 |
|
4863
|
|
|
Fibronectin type III and SPRY domain containing 2 |
SPRYD1 |
|
4864
|
|
|
Follicle stimulating hormone subunit beta |
HH24 |
|
4865
|
|
|
Follicle stimulating hormone receptor |
FSHR1, FSHRO, LGR1, ODG1 |
|
4866
|
|
|
Fibrous sheath interacting protein 1 |
HSD10 |
|
4867
|
|
|
Fibrous sheath interacting protein 2 |
SPGF34 |
|
4868
|
|
|
Follistatin |
FS |
Alzheimer disease, Attention deficit hyperactivity disorder, Breast cancer, Breast neoplasms, Hepatocellular carcinoma, Color vision deficiency, Coronary artery disease, Gout, Hypertension, Keratoconus, Liver failure, Liver neoplasms, Metabolic syndrome, Orofacial cleft, Ovarian serous carcinoma, Polycystic ovary syndrome, Prostate cancer, Stomach neoplasms, Diabetes mellitus type 2View all (4 more) |
4869
|
|
|
Follistatin like 1 |
FRP, FSL1, MIR198, OCC-1, OCC1, tsc36 |
|
4870
|
|
|
Follistatin like 4 |
- |
Attention deficit hyperactivity disorder, Conduct disorder, Endometriosis, Gout, Hypertension, Major depressive disorder, Migraine, Mood disorder, Moyamoya disease, Post-traumatic stress disorder, Dental caries, Prostate cancer, Rheumatoid arthritis, Small cell lung carcinoma, Amyotrophic lateral sclerosis, Diabetes mellitus type 1, Diabetes mellitus type 2View all (2 more) |